AFWM
UTHR icon

Abich Financial Wealth Management’s United Therapeutics UTHR Stock Holding History

Abich Financial Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$43.6K Buy
+104
New +$35K 0.02% 335
2024
Q3 		$2.51K Buy
+7
New +$2.37K 0.01% 324
2024
Q1 		– Sell
-11
Closed -$2.42K – 624
2023
Q4 		$2.42K Buy
+11
New +$2.54K ﹤0.01% 304

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Abich Financial Wealth Management's UTHR Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in United Therapeutics (UTHR) in Q3 2025: 104 shares worth $43.6K. The stake represents 0.02% of the portfolio and ranks #335 among its holdings. This is a return to the name: Abich Financial Wealth Management previously reported a position in UTHR as recently as Q3 2024.

Abich Financial Wealth Management first reported a position in UTHR in Q4 2023 and has held it in 3 quarters since. 707 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Abich Financial Wealth Management held 104 shares of United Therapeutics worth $43.6K as of Q3 2025.
  • United Therapeutics was a new Abich Financial Wealth Management position in Q3 2025.
  • United Therapeutics made up 0.02% of Abich Financial Wealth Management's portfolio in Q3 2025, its #335 holding.
  • Abich Financial Wealth Management first reported a position in United Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • 707 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.